
Request Appointment
2501 N Orange AveSuite 689Orlando, FL 32804
Overview of Dr. Alemany
Dr. Carlos Alemany is an oncologist in Orlando, FL and is affiliated with AdventHealth Orlando. He received his medical degree from Ponce Health Sciences University and has been in practice 20 years. He also speaks multiple languages, including Spanish. He specializes in breast cancer, genitourinary oncology, and hematologic oncology and is experienced in breast cancer, prostate cancer, kidney cancer, bladder cancer, and testicular cancer. He has more than 25 publications and over 450 citings.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2001 - 2004
Cleveland Clinic FoundationResidency, Internal Medicine, 1998 - 2001
Ponce Health Sciences University School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2004 - 2026
OH State Medical License 2000 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha 1997
Clinical Trials
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
- Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer Start of enrollment: 2013 Dec 17
- Join now to see all
Publications & Presentations
PubMed
- Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metast...Erika P Hamilton, Manish R Patel, Virginia F Borges, Jane L Meisel, Meena Okera
Breast Cancer Research. 2025-07-01 - 90 citationsLenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, ran...Toni K Choueiri, Masatoshi Eto, Robert Motzer, Ugo De Giorgi, Tomas Buchler
The Lancet. Oncology. 2023-03-01 - 3 citationsChaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.Amanda Cox, Ana Martini, Heba Ghozlan, Rebecca Moroose, Xiang Zhu
Plos One. 2022-01-01
Committees
- Director, Protocol Review Comittee 2017 - Present
Research History
- Director of Clinical Research, AdventHealth Cancer Institute Orlando2016 - Present
Professional Memberships
- Member
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Illinois PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPOEmpire BCBS HMO
Empire BCBS PPO
First Health PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Medical Mutual of Ohio SuperMed Plus
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









